Spots Global Cancer Trial Database for vaccination
Every month we try and update this database with for vaccination cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer. | NCT02919644 | Stage IV Colore... Curative Resect... | autologous dend... IL2 | 19 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients | NCT01308294 | Melanoma | 2 vaccine injec... 2 vaccine injec... 2 "vaccine inje... | 18 Years - | Centre Hospitalier Universitaire Vaudois | |
| Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials | NCT00487513 | Non-Hodgkin's L... | Procurement of ... | 35 Years - | Dana-Farber Cancer Institute | |
| Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF) | NCT00809588 | Melanoma | Autologous, let... | 18 Years - | Dana-Farber Cancer Institute | |
| PD-L1 Peptide Vaccination in High Risk Smoldering Multiple Myeloma | NCT03850522 | Smoldering Mult... | PD-L1 peptide | 18 Years - | Herlev Hospital | |
| Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine | NCT03542227 | Human Papilloma... | First-void urin... Blood draw | 16 Years - 55 Years | Universiteit Antwerpen | |
| Vaccination Against COVID-19 in Cancer | NCT04715438 | Cancer | mRNA-1273 SARS-... | 18 Years - | University Medical Center Groningen | |
| Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination | NCT02003508 | Human Papilloma... | 17 Years - 19 Years | The Alfred | ||
| PreTeenVax Evaluation | NCT03186430 | Human Papilloma... | Comprehensive V... | 11 Years - 12 Years | Emory University | |
| COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2 | NCT04836793 | Cancer Elderly Healthy Aging | Additional biol... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Response of Immune System to Flu Vaccination in PHTS | NCT03630523 | PTEN Hamartoma ... | Influvac Tetra | 18 Years - | Radboud University Medical Center | |
| Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma | NCT04918940 | Follicular Lymp... Mantle Cell Lym... | Determination o... | 18 Years - | Centre Henri Becquerel | |
| Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment | NCT04872738 | Breast Cancer R... Covid19 | Survey | 18 Years - | Massachusetts General Hospital | |
| Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2 | NCT00197522 | Breast Neoplasm... | CD34+ derived D... | 16 Years - 80 Years | McMaster University | |
| Glioblastoma and Individualized Therapies | NCT05356312 | Glioma, Maligna... | Vaccination | - | Zentrum fur Humangenetik Tuebingen | |
| Engaging Clinical Champions to Improve HPV Vaccination | NCT05736718 | Human Papilloma... | Champion Announ... Traditional Ann... | 9 Years - 12 Years | UNC Lineberger Comprehensive Cancer Center | |
| Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study | NCT05065840 | Human Papilloma... Human Papilloma... | CDC 4 Pillars P... | 18 Years - 45 Years | Emory University | |
| Optimizing Influenza Vaccination in Surgical Oncology Patients | NCT01698177 | Influenza | Influenza vacci... Influenza vacci... | 18 Years - | Stony Brook University | |
| Promise Women Project | NCT05862844 | Human Papilloma... Cervical Cancer | Promise women p... | 18 Years - | University of Kentucky | |
| Study of Health-risk Behaviours (Tobacco, Alcohol or Drug Consumption ; Nutrition ; Sedentary Lifestyle ; Sexual Practices) Among Cancer Survivors | NCT06215365 | Cancer Remissio... | Adult cancer su... | 74 Years - 100 Years | Hospices Civils de Lyon | |
| Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens | NCT00204516 | Malignant Melan... | mRNA coding for... GM-CSF | 18 Years - 80 Years | University Hospital Tuebingen | |
| Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens | NCT00204516 | Malignant Melan... | mRNA coding for... GM-CSF | 18 Years - 80 Years | University Hospital Tuebingen | |
| Hashtag HPV: HPV Vaccine Twitter Education Program | NCT05204030 | Human Papilloma... Vaccine-Prevent... | HPV Twitter Edu... HPV Twitter Edu... | 18 Years - | University of Arkansas, Fayetteville | |
| DC Vaccination for Postremission Therapy in AML | NCT01734304 | Acute Myeloid L... | DC vaccination ... | 18 Years - 75 Years | Ludwig-Maximilians - University of Munich | |
| Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts | NCT04814446 | Palmar or Plant... | Vaccination | 15 Years - | Assistance Publique - Hôpitaux de Paris | |
| DC Vaccination for Postremission Therapy in AML | NCT01734304 | Acute Myeloid L... | DC vaccination ... | 18 Years - 75 Years | Ludwig-Maximilians - University of Munich | |
| Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma | NCT04523688 | Glioblastoma Vaccination | Autologous Dend... Temozolomide | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People | NCT04844489 | Autoimmune or A... HIV Multiple Sclero... Solid Tumors or... Solid Organ Tra... | Blood samples f... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Immunization of Patients With Non Small Cell Lung Cancer (NSCLC) | NCT00793208 | Non Small Cell ... | semi-allogeneic... | 18 Years - | University of Pittsburgh | |
| Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma | NCT00612222 | Metastatic Mela... Skin Cancer | autologous anti... ALVAC MART-1 Va... aldesleukin cyclophosphamid... fludarabine pho... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Gemcitabine and CT-011 for Resected Pancreatic Cancer | NCT01313416 | Pancreatic Neop... Cancer of the P... Neoplasms Pancr... Pancreatic Canc... Pancreas Cancer | CT-011 Gemcitabine | 18 Years - | Augusta University | |
| Hashtag HPV: HPV Vaccine Twitter Education Program | NCT05204030 | Human Papilloma... Vaccine-Prevent... | HPV Twitter Edu... HPV Twitter Edu... | 18 Years - | University of Arkansas, Fayetteville | |
| Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer. | NCT02919644 | Stage IV Colore... Curative Resect... | autologous dend... IL2 | 19 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer | NCT03096093 | Cancer Neoplasms | ACIT-1 | 18 Years - | Cancer Vaccines Limited | |
| A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach | NCT00038415 | Leukemia, Lymph... | CLL vaccine usi... | 18 Years - | M.D. Anderson Cancer Center | |
| HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN) | NCT02087384 | AIN HIV | Gardasil Placebo | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | NCT00683358 | Pancreatic Canc... Pancreas Neopla... | VEGFR1-A24-1084... | 20 Years - 85 Years | Tokyo University | |
| Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study | NCT05065840 | Human Papilloma... Human Papilloma... | CDC 4 Pillars P... | 18 Years - 45 Years | Emory University | |
| Vaccination With PD-L1 Peptide Against Multiple Myeloma | NCT03042793 | Multiple Myelom... | PD-L1 peptide v... | 18 Years - | Herlev Hospital | |
| Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination | NCT03501992 | Papillomavirus ... | Current care Reminder-recall Audit-and-feedb... Combined remind... | 11 Years - 12 Years | Mayo Clinic | |
| Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422) | NCT01127074 | Metastatic Brea... | KS24.22 cells | 18 Years - 80 Years | University Hospital Tuebingen | |
| Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma | NCT00610311 | Metastatic Mela... Skin Cancer | cyclophosphamid... fludarabine pho... Aldesleukin ALVAC gp100 Vac... anti-gp100:154-... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma | NCT00610311 | Metastatic Mela... Skin Cancer | cyclophosphamid... fludarabine pho... Aldesleukin ALVAC gp100 Vac... anti-gp100:154-... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Efficacy and Safety of Endoscopic Ultrasound Guided Fine-needle Injection of Dendritic Cells Vaccination Into Unresectable Pancreatic Cancer | NCT01897636 | Pancreatic Canc... | EUS-guided fine... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study | NCT01824537 | Human Papilloma... | HPV vaccine, Ga... Hepatitis A vac... | 18 Years - 45 Years | McGill University | |
| B-Cell Hematologic Malignancy Vaccination Registry | NCT02298816 | Monoclonal Gamm... Multiple Myelom... Waldenstrom Mac... Lymphocytosis Lymphoma, Non-H... B-Cell Chronic ... Hematological M... | - | Aurora Health Care | ||
| Human Papillomavirus in Young People Epidemiological Research 3 | NCT05587725 | Human Papilloma... HPV HPV Infection Anal Cancer Cancer Men HPV 16 Infectio... | 16 Years - 20 Years | Monash University | ||
| Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | NCT00683085 | Pancreatic Canc... Pancreas Neopla... | HLA-A*02:01-res... | 20 Years - 85 Years | Tokyo University | |
| Mechanisms of Anti COVID-19 Humoral and Cellular Immune Response After Vaccination in a Sample of Patients and Salaried Staff From a French Anti-cancer Center | NCT04935528 | Cancer | serology and EL... serology | 18 Years - | Centre Georges Francois Leclerc | |
| Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People | NCT04844489 | Autoimmune or A... HIV Multiple Sclero... Solid Tumors or... Solid Organ Tra... | Blood samples f... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC | NCT03226236 | Carcinoma, Rena... Vaccination Secondary | boost radiother... Autologous DC v... High-Dose IL-2 | 19 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| B-Cell Hematologic Malignancy Vaccination Registry | NCT02298816 | Monoclonal Gamm... Multiple Myelom... Waldenstrom Mac... Lymphocytosis Lymphoma, Non-H... B-Cell Chronic ... Hematological M... | - | Aurora Health Care | ||
| Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer | NCT00632333 | Esophageal Canc... | URLC10, TTK, KO... | 20 Years - 80 Years | Teikyo University | |
| Hespecta Vaccination in HPV+ Tumors or Malignant Lesions | NCT02821494 | Tumors or Prema... | Hespecta | 18 Years - | Leiden University Medical Center | |
| National Project on Vaccines, COVID-19 and Frail Patients | NCT04848493 | COVID-19 Solid Tumor Hematologic Dis... Neurologic Diso... Rheumatic Disea... | COVID-19 vaccin... | 18 Years - | Azienda Unità Sanitaria Locale Reggio Emilia | |
| Gemcitabine and CT-011 for Resected Pancreatic Cancer | NCT01313416 | Pancreatic Neop... Cancer of the P... Neoplasms Pancr... Pancreatic Canc... Pancreas Cancer | CT-011 Gemcitabine | 18 Years - | Augusta University | |
| Peptide-based Immunization for Colon- and and Pancreas-carcinoma | NCT03871790 | Colon Neoplasm Colon Adenocarc... Colon Cancer Colo-rectal Can... Rectal Cancer Rectal Neoplasm... Rectal Adenocar... Rectal Tumors Pancreatic Canc... Pancreas Cancer Pancreatic Neop... Pancreatic Aden... | 18 Years - | CENTOGENE GmbH Rostock | ||
| Promise Women Project | NCT05862844 | Human Papilloma... Cervical Cancer | Promise women p... | 18 Years - | University of Kentucky | |
| Novel Peptide Vaccination for Patients With Advanced Bladder Cancer | NCT00635336 | Bladder Cancer | MPHOSPH1 and DE... | 20 Years - 80 Years | Iwate Medical University | |
| Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study | NCT01973322 | Malignant Melan... Malignant Melan... | arm 1: DC Vacci... arm 2: DC Vacci... arm 3: both arm... arm 4: DC Vacci... | 18 Years - 70 Years | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Efficacy and Safety of Endoscopic Ultrasound Guided Fine-needle Injection of Dendritic Cells Vaccination Into Unresectable Pancreatic Cancer | NCT01897636 | Pancreatic Canc... | EUS-guided fine... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer Patients | NCT04953065 | Malignancies Mu... | COVID-19 vaccin... | 18 Years - 89 Years | Milton S. Hershey Medical Center | |
| Impact of HPV Vaccination on Cervical High Grade Lesions in France | NCT04167501 | Human Papilloma... | biological samp... | 27 Years - 46 Years | Centre Hospitalier Universitaire de Besancon | |
| Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma | NCT00612222 | Metastatic Mela... Skin Cancer | autologous anti... ALVAC MART-1 Va... aldesleukin cyclophosphamid... fludarabine pho... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer | NCT00995358 | Esophageal Canc... | peptide | 20 Years - 80 Years | University of Yamanashi | |
| Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination | NCT03501992 | Papillomavirus ... | Current care Reminder-recall Audit-and-feedb... Combined remind... | 11 Years - 12 Years | Mayo Clinic | |
| HPV Message Testing and Social Media Campaign | NCT03747302 | Vaccine Human Papilloma... | Social Media Me... Social media me... | - | Dartmouth-Hitchcock Medical Center | |
| Vaccination With PD-L1 Peptide Against Multiple Myeloma | NCT03042793 | Multiple Myelom... | PD-L1 peptide v... | 18 Years - | Herlev Hospital | |
| Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28 | NCT00204594 | Malignant Melan... | rM28 autologous PBMC... | 18 Years - 75 Years | University Hospital Tuebingen | |
| Vaccination With Peptides From Anti-apoptotic Proteins in Relapsed Multiple Myeloma | NCT01272466 | Relapsed Multip... | peptides derive... | 18 Years - 90 Years | Herlev Hospital | |
| Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2 | NCT00197522 | Breast Neoplasm... | CD34+ derived D... | 16 Years - 80 Years | McMaster University | |
| Optimizing Influenza Vaccination in Surgical Oncology Patients | NCT01698177 | Influenza | Influenza vacci... Influenza vacci... | 18 Years - | Stony Brook University | |
| Dendritic Cells (DC) Vaccine for Metastatic Melanoma | NCT01042366 | Metastatic Mela... | Vaccination | 18 Years - | University of Pittsburgh | |
| A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer | NCT00995358 | Esophageal Canc... | peptide | 20 Years - 80 Years | University of Yamanashi | |
| Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II) | NCT01267578 | Esophageal Canc... | vaccination | 20 Years - 80 Years | University of Yamanashi | |
| Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma | NCT04918940 | Follicular Lymp... Mantle Cell Lym... | Determination o... | 18 Years - | Centre Henri Becquerel | |
| Impact of HPV Vaccination on Cervical High Grade Lesions in France | NCT04167501 | Human Papilloma... | biological samp... | 27 Years - 46 Years | Centre Hospitalier Universitaire de Besancon | |
| Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma | NCT04918940 | Follicular Lymp... Mantle Cell Lym... | Determination o... | 18 Years - | Centre Henri Becquerel | |
| Human Papilloma Virus Vaccination in Girls With Cystic Fibrosis (VACCIN-HPV-MUC2) | NCT03653377 | Mucoviscidosis | Self administra... | 9 Years - 18 Years | Hospices Civils de Lyon | |
| Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection | NCT00243594 | Melanoma Stage ... | Peptide-pulsed ... | 18 Years - 75 Years | Radboud University Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
